Bioavailability of Duloxetine 60 mg With Regards to Reference Product in Fasting Conditions
Status:
Completed
Trial end date:
2021-03-26
Target enrollment:
Participant gender:
Summary
This Study will investigate the bioavailability in fasting subjects of 1 capsule formulation
containing Duloxetine 60 mg. The Study will be performed at a single site with 36 subjects.
Participants will take 1 capsule of the test product and reference product in 2 periods and 2
sequences (either test after reference or reference after test). There will be a washout of
at least 14 days between each study period.